A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation

Introduction No proven treatments exist for bronchiolitis obliterans syndrome (BOS) following lung transplantation. Inhaled liposomal cyclosporine (L-CsA) may prevent BOS progression. Methods A 48-week phase IIb randomised clinical trial was conducted in 21 lung transplant patients with BOS assigned...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Aldo Iacono, Marniker Wijesinha, Keshava Rajagopal, Natalia Murdock, Irina Timofte, Bartley Griffith, Michael Terrin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	European Respiratory Society 2019-10-01
Edice:	ERJ Open Research
On-line přístup:	http://openres.ersjournals.com/content/5/4/00167-2019.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!